• linkedin
  • Increase Font
  • Sharebar

    Top 5 dermatology controversies


    #5: Comparing Neurotoxins

    “Although Botox was been the only neurotoxin available in the U.S. until the last few years, the introduction of Dysport and Xeomin has stirred up arguments about the variable potency of each. Although they are classified as different toxins, they appear to have more in common than not,” Dr. Coleman says. “A number of scientific studies have set out to determine whether or not they can be used clinically to achieve the same results and longevity. A recent study published in Dermatologic Surgery determined that Botox and Xeomin were quite comparable. Because of the large markets involved, we can expect that the three manufacturers will continue to debate the potency and longevity of their competitors.”1

    Derms speak up

    The recent publication comparing Botox and Xeomin head to head proves that in the glabella, Xeomin and Botox perform equally within bounds of statistical significance, according to Dr. Jones.

    RECOMMENDED: Best practices for neurotoxins

    “However, there will be patients or practitioners who favor one product over another for a variety of reasons,” Dr. Jones says.

    Dr. Green says he agrees with Dr. Coleman’s take on the controversy.

    “I find in clinical practice that the three toxins behave quite similarly. The most dissimilar characteristic is the name recognition that Botox continues to enjoy as the 'first kid on the block,'” Dr. Green says.

    Lisette Hilton
    Lisette Hilton is president of Words Come Alive, based in Boca Raton, Florida.


    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available

    Latest Tweets Follow